Allosteros Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Allosteros Therapeutics General Information

Description

Developer of targeting drugs designed to target key proteins in cardiovascular disease signaling pathways. The company's drugs are novel, potent, and selective small molecule which signal pathway that promotes heart disease, enabling customers to get candidate selection and planned stepwise development of inhibitors for several cardiovascular indications.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 560 Pena Court
  • Palo Alto, CA 94306
  • United States
+1 (650)
Primary Industry
Drug Discovery
Corporate Office
  • 560 Pena Court
  • Palo Alto, CA 94306
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allosteros Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 08-May-2020 Completed Out of Business
5. Grant 18-Sep-2017 Completed Generating Revenue
4. Grant 01-Jan-2017 Completed Generating Revenue
3. Debt - General 20-Aug-2012 Completed Generating Revenue
2. Grant 01-Jan-2012 $1.25M $1.03M Completed Generating Revenue
1. Seed Round 18-Oct-2010 $1.03M $1.03M Completed Generating Revenue
To view Allosteros Therapeutics’s complete valuation and funding history, request access »

Allosteros Therapeutics Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Allosteros Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015311730-A1 Camkii inhibitors and uses thereof Inactive 05-Sep-2014
AU-2015311730-A8 Camkii inhibitors and uses thereof Inactive 05-Sep-2014
WO-2016037106-A1 Camkii inhibitors and uses thereof Inactive 05-Sep-2014
CA-2901155-A1 Camkii inhibitors and uses thereof Active 06-Mar-2013
CA-2901155-C Camkii inhibitors and uses thereof Active 06-Mar-2013 C07D471/04
To view Allosteros Therapeutics’s complete patent history, request access »

Ready to get started?

Request a free trial

Allosteros Therapeutics FAQs

  • When was Allosteros Therapeutics founded?

    Allosteros Therapeutics was founded in 2010.

  • Where is Allosteros Therapeutics headquartered?

    Allosteros Therapeutics is headquartered in Palo Alto, CA.

  • What industry is Allosteros Therapeutics in?

    Allosteros Therapeutics’s primary industry is Drug Discovery.

  • Is Allosteros Therapeutics a private or public company?

    Allosteros Therapeutics is a Private company.

  • What is Allosteros Therapeutics’s current revenue?

    The current revenue for Allosteros Therapeutics is .

  • How much funding has Allosteros Therapeutics raised over time?

    Allosteros Therapeutics has raised $1.32M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process